HIV Clinical Trial
Official title:
The Impact of Structured Exercise on Brain Health in HIV Positive Individuals
Exercise programs that combine resistance exercise with aerobic training yield optimal
health benefits for people with HIV. The global aim of this study is to contribute evidence
for the impact potential of a comprehensive exercise program on brain health in people with
HIV.
This study is part of a larger project based upon a cohort multiple randomized controlled
design. Within a fully characterized cohort which is followed over time, people meeting the
specific criteria for an exercise intervention will be identified. The sample will be
randomly selected to receive the intervention; the remaining eligible persons will serve as
controls. The intervention group will receive a 45 minute structured exercise program 3
times a week consisting of aerobic exercise and resistance training for a total of 12 weeks.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | December 2018 |
| Est. primary completion date | January 2018 |
| Accepts healthy volunteers | No |
| Gender | Male |
| Age group | 35 Years to 80 Years |
| Eligibility |
The exercise intervention will target individuals recruited from two Montreal clinics who
identified at cohort entry they were interested in being approached for different trials
if they eligible. Inclusion Criteria: - men and women aged = 35 years, HIV+ for at least 1 year, able to communicate adequately in either French or English, and able to give written informed consent. Also, participants must identify that they are mostly sedentary by reporting that they perform moderate level physical activity of 30 minutes duration less than twice a week or have limitations in performing vigorous activities, walking a kilometer, or climbing stairs. Individuals answering yes to any of the Physical Activities Readiness Questionnaire (PAR-Q) (Thomas et al., 1992) items except taking medication (Item 6) will require clearance from their physician to be included. Exclusion Criteria: - people with dementia (MOCA < 18) or treating physician's concern about capacity to consent, life expectancy of < 3 years or other personal factors limiting the ability to participate in follow-up, non-HIV-related neurological disorder likely to affect cognition, known active CNS opportunistic infection or hepatitis C requiring interferon (IFN) treatment during the follow-up period, psychiatric disorder on the psychotic axis, current substance use disorder or severe substance use disorder within the past 12 months. Also excluded will be people with a contraindication for exercise from cardiovascular or musculoskeletal co-morbidity as gathered from the medical history and from the PAR-Q (Thomas et al., 1992). |
| Country | Name | City | State |
|---|---|---|---|
| Canada | Division of Clinical Epidemiology | Montreal | Quebec |
| Lead Sponsor | Collaborator |
|---|---|
| McGill University | Canadian Institutes of Health Research (CIHR), Universite du Quebec a Montreal |
Canada,
Lee SY, Gallagher D. Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):566-72. doi: 10.1097/MCO.0b013e32830b5f23. Review. — View Citation
Macintyre NJ, Lorbergs AL. Imaging-Based Methods for Non-invasive Assessment of Bone Properties Influenced by Mechanical Loading. Physiother Can. 2012 Spring;64(2):202-15. doi: 10.3138/ptc.2011-08bh. — View Citation
Malita FM, Karelis AD, Toma E, Rabasa-Lhoret R. Effects of different types of exercise on body composition and fat distribution in HIV-infected patients: a brief review. Can J Appl Physiol. 2005 Apr;30(2):233-45. Review. — View Citation
Mullen SP, Olson EA, Phillips SM, Szabo AN, Wójcicki TR, Mailey EL, Gothe NP, Fanning JT, Kramer AF, McAuley E. Measuring enjoyment of physical activity in older adults: invariance of the physical activity enjoyment scale (paces) across groups and time. Int J Behav Nutr Phys Act. 2011 Sep 27;8:103. doi: 10.1186/1479-5868-8-103. — View Citation
Relton C, Torgerson D, O'Cathain A, Nicholl J. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ. 2010 Mar 19;340:c1066. doi: 10.1136/bmj.c1066. — View Citation
Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci. 1992 Dec;17(4):338-45. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Cognitive Ability | The primary outcome is cognitive ability as measured by B-CAM. This is part of the measurement platform for all and the value taken at the regular assessment prior to the exercise intervention will serve as the baseline value and the subsequent evaluation 9 months following will serve as the follow-up value. The strategy ensures that the intervention cohort does not have additional measurements of cognitive ability than the control cohort. The items on the B-CAM fit the Rasch Model and as such have linearized units on a logit scale. | 0 and 39 weeks | |
| Secondary | Change in depression | Measured by Hospital Anxiety and Depression Scale (HADS) | 0 and 39 weeks | |
| Secondary | Change in depression | Measured by RAND -36 Mental Health Inventory (MHI) | 0 and 39 weeks | |
| Secondary | Change in stress levels | Measured by Trier Inventory for Chronic Stress (TICS) | 0 and 39 weeks | |
| Secondary | Change in anxiety | Measured by Hospital Anxiety and Depression Scale (HADS) | 0 and 39 weeks | |
| Secondary | Change in fatigue | Measured by RAND-36 Vitality | 0 and 39 weeks | |
| Secondary | Change in motivation | Measured by Motivation Ladder | 0 and 39 weeks | |
| Secondary | Change in global quality of life (QOL) | Measured by Person Generated Index (PGI) | 0 and 39 weeks | |
| Secondary | Change in health related quality of life (HRQoL) | Measured by RAND-36 | 0 and 39 weeks | |
| Secondary | Change in health related quality of life (HRQoL) | Measured by WHOQOL-HIV | 0 and 39 weeks | |
| Secondary | Change in measures of brain network function | The measures of brain network function are derived from event related potential (ERPs) which are electric potentials produced by the brain in response to auditory or visual stimulation, respectively. These brain responses are easily recorded noninvasively with scalp electrodes (EEG). ERPs allow insights into the neural mechanisms underlying specific cognitive processes. The potentials of interest here include the N1, N2, P2 and P3 ERPs. | 0 and 12 weeks | |
| Secondary | Change in skeletal muscle mass | A total body Dual energy X-ray absorptiometry (DEXA) scan will be done to compute skeletal muscle mass (whole body, spine and thigh) (Lee & Gallagher, 2009). | 0 and 12 weeks | |
| Secondary | Change in muscle quality | Peripheral quantitative computed tomography (pQCT) will be used to measure the muscle quality in lower extremity (MacIntyre & Lorbergs, 2012). | 0 and 12 weeks | |
| Secondary | Change in exercise capacity | Measured by step test | 0 and 12 weeks | |
| Secondary | Change in functional walking capacity | Measured by Six Minute Walk Test (6MWT) | 0 and 12 weeks | |
| Secondary | Change in quadriceps power | Measured using leg press and jump test | 0 and 12 weeks | |
| Secondary | Change in core strength | Measured using curl ups/push ups | 0 and 12 weeks | |
| Secondary | Change in grip strength | Measured using hand dynamometer | 0 and 12 weeks | |
| Secondary | Change in gait speed | Comfortable gait speed: GAITRite; Fast gait speed: GAITRite; Dual task gait speed: GAITRite and naming the fruits | 0 and 12 weeks | |
| Secondary | Change in exercise enjoyment | Exercise enjoyment will be measured by Physical Activity Enjoyment Scale (PACES) (Mullen et al., 2011). | 0 and 12 weeks | |
| Secondary | Change in physical activity | The data from the accelerometer will be used to estimate the extent to which the structured exercise program carries over into everyday life. Participants will be asked to wear an ActivPal accelerometer for 5-7 days prior to the start of the intervention, at 6 weeks, and after 12 weeks, to objectively measure habitual physical activity. | 0, 6 and 12 weeks | |
| Secondary | Change in semantic fluency | Following question will be asked: Name as many animals as you can in 1 minute (in sitting). |
0 and 12 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |